Cardinal Health, Inc. (CAH) Net Profit Margin: 0.62%
Is Cardinal Health, Inc.’s net profit margin high or low?
Cardinal Health, Inc.'s net profit margin of 0.62% is 384% above its 5-year average of -0.22%, near the high end of its 5-year range (-2.41%–0.70%).
As of Monday, June 15, 2026. 14.81% above its 12-month average of 0.54%.
CAH Net Profit Margin Chart
CAH Average Net Profit Margin Chart
CAH Current vs Average Net Profit Margin Chart
CAH Net Profit Margin Metrics
NET PROFIT MARGIN
0.62%
NET PROFIT MARGIN AVG TTM
0.54%
NET PROFIT MARGIN AVG 3Y
0.18%
NET PROFIT MARGIN AVG 5Y
-0.22%
NET PROFIT MARGIN AVG 10Y
0.29%
NET PROFIT MARGIN AVG 15Y
0.65%
NET PROFIT MARGIN AVG 20Y
0.87%
CURRENT VS TTM AVG
+14.81%
CURRENT VS 3Y AVG
+244.44%
CURRENT VS 5Y AVG
+383.97%
CURRENT VS 10Y AVG
+115.14%
CURRENT VS 15Y AVG
-4.71%
CURRENT VS 20Y AVG
-28.65%
CAH Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $52.43B | 0.62% | 0.54% | 0.18% | -0.22% |
| Becton, Dickinson and Company (BDX)vs › | $52.98B | 5.33% | 8.06% | 8.30% | 8.27% |
| Cencora, Inc. (COR)vs › | $54.80B | 0.78% | 0.49% | 0.59% | 0.22% |
| Humana Inc. (HUM)vs › | $45.53B | 0.82% | 0.97% | 1.82% | 2.53% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.24B | 24.63% | 23.70% | 22.66% | 22.55% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.06B | 29.65% | 31.24% | 32.06% | 36.64% |
| Agilent Technologies, Inc. (A)vs › | $36.67B | 19.55% | 19.27% | 18.75% | 17.94% |
| Zoetis Inc. (ZTS)vs › | $33.36B | 27.79% | 27.55% | 27.17% | 26.57% |
| Centene Corporation (CNC)vs › | $32.19B | -3.25% | -0.70% | 0.29% | 0.65% |
| Medline Inc. (MDLN)vs › | $30.96B | 3.31% | 4.39% | 2.42% | 2.42% |
Margin Comparison
Operating Margin
0.9%
Net Profit Margin
0.6%
Cardinal Health, Inc. Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cardinal Health, Inc. Net Profit Margin FAQ
- What is the net profit margin for Cardinal Health, Inc. (CAH)?
- The net profit margin for CAH stock is 0.62%.
- Is Cardinal Health, Inc.'s net profit margin high or low?
- Cardinal Health, Inc.'s net profit margin of 0.62% is 384% above its 5-year average of -0.22%, near the high end of its 5-year range (-2.41%–0.70%).
- What is the TTM average net profit margin for Cardinal Health, Inc. (CAH)?
- The TTM average net profit margin for CAH stock is 0.54%.
- What is the 3Y average net profit margin for Cardinal Health, Inc. (CAH)?
- The 3Y average net profit margin for CAH stock is 0.18%.
- What is the 5Y average net profit margin for Cardinal Health, Inc. (CAH)?
- The 5Y average net profit margin for CAH stock is -0.22%.
- What is the 10Y average net profit margin for Cardinal Health, Inc. (CAH)?
- The 10Y average net profit margin for CAH stock is 0.29%.
- What is the 15Y average net profit margin for Cardinal Health, Inc. (CAH)?
- The 15Y average net profit margin for CAH stock is 0.65%.
- What is the 20Y average net profit margin for Cardinal Health, Inc. (CAH)?
- The 20Y average net profit margin for CAH stock is 0.87%.
Cardinal Health, Inc. Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-06-30 | 0.70% |
| 2024-06-30 | 0.38% |
| 2023-06-30 | 0.16% |
| 2022-06-30 | -0.52% |
| 2021-06-30 | 0.38% |
| 2020-06-30 | -2.41% |
| 2019-06-30 | 0.94% |
| 2018-06-30 | 0.19% |
| 2017-06-30 | 0.99% |
| 2016-06-30 | 1.17% |
| 2015-06-30 | 1.19% |
| 2014-06-30 | 1.28% |
| 2013-06-30 | 0.33% |
| 2012-06-30 | 0.99% |
| 2011-06-30 | 0.93% |
| 2010-06-30 | 0.65% |
| 2009-06-30 | 1.20% |
| 2008-06-30 | 1.49% |
| 2007-06-30 | 2.22% |
| 2006-06-30 | 1.26% |
| 2005-06-30 | 1.45% |
| 2004-06-30 | 2.29% |
| 2003-06-30 | 2.48% |
| 2002-06-30 | 2.07% |
| 2001-06-30 | 1.79% |
| 2000-06-30 | 1.77% |
| 1999-06-30 | 1.82% |
| 1998-06-30 | 1.17% |
| 1997-06-30 | 0.98% |
| 1996-06-30 | 1.21% |
Related Metrics
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar